Bulk Manufacturer of Controlled Substances Application: Johnson Matthey Pharmaceutical Materials Inc., 27632 [2018-12685]
Download as PDF
<![CDATA[
27632
Federal Register / Vol. 83, No. 114 / Wednesday, June 13, 2018 / Notices
Dated: June 1, 2018.
Robert W. Patterson,
Acting Administrator.
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 13, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
[FR Doc. 2018–12686 Filed 6–12–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
ACTION:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
SUPPLEMENTARY INFORMATION:
Bulk Manufacturer of Controlled
Substances Application: Johnson
Matthey Pharmaceutical Materials Inc.
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
DATES:
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on January
1, 2018, Johnson Matthey
Pharmaceutical Materials Inc., 25 Patton
Road, Devens, MA 01434 applied to be
registered as a bulk manufacturer for the
basic classes of controlled substances:
Controlled substance
Drug code
Amphetamine ...................................................................................................................................................................
Methylphenidate ..............................................................................................................................................................
Nabilone ...........................................................................................................................................................................
Hydrocodone ...................................................................................................................................................................
Levorphanol .....................................................................................................................................................................
Alfentanil ..........................................................................................................................................................................
Remifentanil .....................................................................................................................................................................
Sufentanil .........................................................................................................................................................................
The company plans to utilize this
facility to manufacture small quantities
of the listed controlled substances in
bulk for distribution to its customers as
well as to conduct analytical testing in
support of the company’s primary
manufacturing facility in West Deptford,
New Jersey.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration
ACTION:
Dated: June 6, 2018.
John J. Martin,
Assistant Administrator.
Notice of registration.
Registrants listed below have
applied for and been granted
registration by-the Drug Enforcement
Administration (DEA) as importers of
SUMMARY:
[FR Doc. 2018–12685 Filed 6–12–18; 8:45 am]
BILLING CODE 4410–09–P
The
companies listed below applied to be
registered as importers of various basic
classes of controlled substances.
Information on previously published
notices is listed in the table below. No
comments or objections were submitted
and no requests for hearing were
submitted for these notices.
FR docket
amozie on DSK3GDR082PROD with NOTICES1
18:01 Jun 12, 2018
Jkt 244001
protocols in effect on May 1, 1971. The
DEA investigated each company’s
maintenance of effective controls
against diversion by inspecting and
testing each company’s physical
security systems, verifying each
company’s compliance with state and
local laws, and reviewing each
company’s background and history.
PO 00000
Frm 00095
Fmt 4703
Sfmt 4703
II
II
II
II
II
II
II
II
SUPPLEMENTARY INFORMATION:
PerkinElmer, Inc ...................................................................................................................................................
Stepan Company ..................................................................................................................................................
Noramco, Inc ........................................................................................................................................................
Sanyal Biotechnology ...........................................................................................................................................
S&B Pharma, Inc ..................................................................................................................................................
Siegfried USA, LLC ..............................................................................................................................................
Lannett Company, Inc ..........................................................................................................................................
VerDate Sep<11>2014
1100
1724
7379
9193
9220
9737
9739
9740
various classes of schedule I or II
controlled substances.
Company
The Drug Enforcement
Administration (DEA) has considered
the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the
registration of the listed registrants to
import the applicable basic classes of
schedule I or II controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
Schedule
83
83
83
83
83
83
83
FR
FR
FR
FR
FR
FR
FR
9337
9337
12408
12407
13523
13521
13520
Published
March
March
March
March
March
March
March
5, 2018.
5, 2018.
21, 2018.
21, 2018.
29, 2018.
29, 2018.
29, 2018.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
granted a registration as an importer for
schedule I or II controlled substances to
the above listed companies.
E:\FR\FM\13JNN1.SGM
13JNN1
]]>Agencies
[Federal Register Volume 83, Number 114 (Wednesday, June 13, 2018)]
[Notices]
[Page 27632]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-12685]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Johnson
Matthey Pharmaceutical Materials Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before August 13, 2018.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on
January 1, 2018, Johnson Matthey Pharmaceutical Materials Inc., 25
Patton Road, Devens, MA 01434 applied to be registered as a bulk
manufacturer for the basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Amphetamine.............................. 1100 II
Methylphenidate.......................... 1724 II
Nabilone................................. 7379 II
Hydrocodone.............................. 9193 II
Levorphanol.............................. 9220 II
Alfentanil............................... 9737 II
Remifentanil............................. 9739 II
Sufentanil............................... 9740 II
------------------------------------------------------------------------
The company plans to utilize this facility to manufacture small
quantities of the listed controlled substances in bulk for distribution
to its customers as well as to conduct analytical testing in support of
the company's primary manufacturing facility in West Deptford, New
Jersey.
Dated: June 6, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-12685 Filed 6-12-18; 8:45 am]
BILLING CODE 4410-09-P
